Società Aurinia Pharmaceuticals Inc. Toronto S.E.
Azioni
CA05156V1022
Biotecnologia
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutic Drugs
100,0
%
| 134 | 100,0 % | 176 | 100,0 % | +30,95% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
90,0
%
| 102 | 76,4 % | 158 | 90,0 % | +54,17% |
Japan
10,0
%
| 31 | 23,5 % | 18 | 10,0 % | -44,24% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Michael Martin
FOU | Founder | 52 | 16/06/93 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 29/04/19 |
Robert Foster
FOU | Founder | 65 | 16/06/93 |
Joseph Miller
DFI | Director of Finance/CFO | 50 | 27/04/20 |
Compliance Officer | 42 | 01/01/14 | |
Matthew Donley
COO | Chief Operating Officer | 55 | 18/07/19 |
Sue Evans
LAW | General Counsel | - | 01/01/14 |
Fran Lynch
SAM | Sales & Marketing | - | 25/02/20 |
Scott Habig
PRN | Corporate Officer/Principal | 64 | 15/07/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Robert Foster
FOU | Founder | 65 | 16/06/93 |
R. MacKay-Dunn
BRD | Director/Board Member | 73 | 26/06/19 |
Peter Greenleaf
CEO | Chief Executive Officer | 54 | 29/04/19 |
Jill Leversage
BRD | Director/Board Member | 67 | 13/11/19 |
Jeffrey Bailey
BRD | Director/Board Member | 62 | 18/08/23 |
Michael Martin
FOU | Founder | 52 | 16/06/93 |
Karen Smith
BRD | Director/Board Member | 56 | 18/08/23 |
David Jaynee
BRD | Director/Board Member | 67 | 26/05/15 |
Director/Board Member | 44 | 14/06/21 | |
Daniel Billen
CHM | Chairman | 70 | 29/04/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 143 019 365 | 132 907 345 ( 92,93 %) | 0 | 92,93 % |
Coordinate società
Aurinia Pharmaceuticals, Inc.
14315 – 118 Avenue Suite 140
T5L 4S6, Edmonton
+250 744 2487
http://www.auriniapharma.comSettore
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+20,17% | 127 Mrd | |
+24,67% | 117 Mrd | |
+25,44% | 27,67 Mrd | |
-17,74% | 20,33 Mrd | |
-15,17% | 16,79 Mrd | |
-15,21% | 15,63 Mrd | |
+11,91% | 14,84 Mrd | |
-47,10% | 14,65 Mrd | |
+54,50% | 14,43 Mrd |